A0276356
(3S)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one
Synonym(s):
1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride;GR 38032F;Ondansetron hydrochloride dihydrate
CAS NO.:
Empirical Formula: C18H19N3O·HCl·2H2O
Molecular Weight: 365.85
MDL number: MFCD00833882
EINECS: 600-465-5
Pack Size | Price | Stock | Quantity |
250mg | RMB1018.40 | In Stock |
|
1g | RMB2160.80 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 231-232 C |
storage temp. | -20°C |
solubility | H2O: >5mg/mL |
form | powder |
color | white |
InChIKey | FELGMEQIXOGIFQ-ZDUSSCGKSA-N |
CAS DataBase Reference | 103639-04-9(CAS DataBase Reference) |
Description and Uses
Ondansetron hydrochloride is a selective 5HT3-antagonist approved for the management of nausea and vomiting induced by cancer chemotherapy and radiotherapy. It is reported to have a superior side-effect profile compared with metoclopramide, representing an important advance in the treatment of nausea and vomiting associated with chemotherapy. Ondansetron hydrochloride is the first specific 5HT3-antagonist to reach the market. It is also under investigation for a number of other indications, including anxiety and schizophrenia.
A serotonin type 3 receptor antagonist.
Safety
Symbol(GHS) | GHS05,GHS06,GHS09 |
Signal word | Danger |
Hazard statements | H301-H318-H410 |
Precautionary statements | P273-P280-P301+P310+P330-P305+P351+P338+P310 |
Hazard Codes | T,Xi |
Risk Statements | 25-36/37/38-50/53-41 |
Safety Statements | 45-37/39-26-61-39 |
RIDADR | UN 2811 |
WGK Germany | 3 |
RTECS | FE6375500 |
HazardClass | 6.1 |
PackingGroup | III |
HS Code | 2933290000 |